Significant Ownership of Propel Bio Management, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Propel Bio Management, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Leen Kawas - Managing Member
- Manager location
- Los Angeles, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Propel Bio Management, LLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Propel Bio Management, LLC
Significant Ownership of Propel Bio Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | Common Stock | 9.9% | $21,001,011 | 8,861,186 | Propel Bio Management, LLC | 11 Jul 2025 | ||
| APLT | Applied Therapeutics, Inc. | Common Stock | 4.2% | $1,564,002 | 6,015,394 | Propel Bio Management, LLC | 29 Dec 2025 |
Schedules 13D/G Reported by Propel Bio Management, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.